CANADA LIFE ASSURANCE Co Has $4.20 Million Position in Maximus, Inc. (NYSE:MMS)

CANADA LIFE ASSURANCE Co cut its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 6.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 56,239 shares of the health services provider's stock after selling 4,052 shares during the quarter. CANADA LIFE ASSURANCE Co owned approximately 0.10% of Maximus worth $4,197,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. UMB Bank n.a. raised its holdings in shares of Maximus by 79.8% during the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock valued at $27,000 after buying an additional 158 shares during the last quarter. Eastern Bank bought a new position in shares of Maximus in the fourth quarter worth $29,000. V Square Quantitative Management LLC increased its holdings in shares of Maximus by 65.9% during the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock valued at $34,000 after purchasing an additional 180 shares during the period. R Squared Ltd bought a new stake in shares of Maximus during the fourth quarter valued at about $54,000. Finally, IFP Advisors Inc grew its position in Maximus by 62.4% in the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after buying an additional 302 shares in the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on MMS shares. StockNews.com lowered shares of Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th. Raymond James upgraded Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price target on the stock in a research report on Thursday, January 2nd.

Maximus Price Performance

NYSE:MMS traded down $0.41 during trading hours on Wednesday, reaching $66.98. 539,862 shares of the company's stock were exchanged, compared to its average volume of 555,960. The company has a market capitalization of $3.79 billion, a P/E ratio of 14.40 and a beta of 0.68. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.97. The business's 50-day simple moving average is $67.66 and its two-hundred day simple moving average is $74.14. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMS - Get Free Report) last issued its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Sell-side analysts expect that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.79%. The ex-dividend date of this dividend is Thursday, May 15th. Maximus's dividend payout ratio is presently 25.81%.

Insiders Place Their Bets

In other news, Director Jan Madsen sold 2,439 shares of Maximus stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the transaction, the director now owns 18,097 shares in the company, valued at approximately $1,225,347.87. The trade was a 11.88 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Ilene R. Baylinson sold 14,500 shares of the company's stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the transaction, the insider now directly owns 2,512 shares in the company, valued at $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company's stock.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.